Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Short-course Radiotherapy Followed by Chemotherapy With or Without PD-1 Inhibitor for Locally Advanced Rectal Cancer: a Prospective, Multicenter, Randomized Controlled, Phase II/III Study (STELLAR II Study)

NCT05484024 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT05484024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05484024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Short-course Radiotherapy Followed by Chemotherapy With or Without PD-1 Inhibitor for Locally Advanced Rectal Cancer: a Prospective, Multicenter, Randomized Controlled, Phase II/III Study (STELLAR II Study)
Lead sponsor
Chinese Academy of Medical Sciences
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
August 6, 2022
Completion date
July 31, 2030
Enrollment
588 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

radiotherapy, rectal neoplasms malignant